Akshara Srivastava, Sanket Koul

Stories by Akshara Srivastava, Sanket Koul

New Covid-Like Virus Found In Bats

New Covid-Like Virus Found In Bats

Rediff.com   2 days ago

Scientists stress there is currently no evidence of human infections, or community spread linked to the virus.

Weight Loss Drugs Sales Surge!

Weight Loss Drugs Sales Surge!

Rediff.com   4 days ago

'The innovators have been able to more or less stay where they are, in terms of revenue even as the generics are seeing exponential growth due to their affordability.'

Ralph Lauren Faces Heat Over Bandhani Skirt

Ralph Lauren Faces Heat Over Bandhani Skirt

Rediff.com   6 May 2026

'It is disappointing that a craft, which is protected by the Geographical Indication Tag, Polo Ralph Lauren has turned it into a cheap wrap skirt, that too, printed.'

Affordable housing may lose more ground as costs rise

Affordable housing may lose more ground as costs rise

Rediff.com   5 May 2026

The ongoing West Asia conflict is expected to severely impact the supply of affordable housing in India, as rising input costs further erode already thin developer margins. Fluctuations in crude oil and gas prices, coupled with higher freight costs, are driving up prices of essential construction materials like cement and steel, making new projects increasingly unviable for developers.

Chinese API price surge tests India's pharma buffers amid West Asia crisis

Chinese API price surge tests India's pharma buffers amid West Asia crisis

Rediff.com   2 May 2026

India's pharmaceutical industry is experiencing increased bulk drug prices, particularly for APIs from China, following the escalation of the West Asia crisis in March. While current inventories provide a temporary buffer, concerns are mounting over the availability of key solvents and feedstocks, potentially leading to manufacturing disruptions and shortages in specific drug categories.

Canada first G7 nation to okay Dr Reddy's generic version of semaglutide

Canada first G7 nation to okay Dr Reddy's generic version of semaglutide

Rediff.com   30 Apr 2026

Dr Reddy's Laboratories has received approval from Health Canada to sell a generic version of the diabetes drug semaglutide, making it the first company to get market authorisation for a generic semaglutide injection in Canada and the first in a G7 country.

Brands chase flyers as new airports open a runway to revenue for retail

Brands chase flyers as new airports open a runway to revenue for retail

Rediff.com   27 Apr 2026

Indian airports are rapidly becoming a significant growth avenue for the country's retail sector, with brands across various consumer segments actively opening stores to tap into the increasing number of flyers and strong domestic tourism momentum.

War, Rain Dampen Q4 Consumer Durables Sales, Especially ACs

War, Rain Dampen Q4 Consumer Durables Sales, Especially ACs

Rediff.com   20 Apr 2026

Increased input costs due to geopolitical conflict in West Asia and unseasonal rain in March negatively impacted volumes of consumer durables makers, particularly air conditioners, in Q4FY26, leading to projected declines in EBITDA and APAT despite revenue growth.

Pressure builds on developers to hike prices as costs rise

Pressure builds on developers to hike prices as costs rise

Rediff.com   13 Apr 2026

Indian realty developers are contemplating price increases for ongoing and upcoming projects to offset margin pressures caused by rising input costs and supply chain disruptions, exacerbated by the West Asia conflict. Input and labour costs have surged by 5-12%, directly impacting developer margins, especially for under-construction projects.

Indian HNIs maintain grip on Dubai luxury real estate despite West Asia tensions

Indian HNIs maintain grip on Dubai luxury real estate despite West Asia tensions

Rediff.com   6 Apr 2026

Ongoing geopolitical tensions in West Asia have slowed deal momentum in Dubai's luxury residential market, but Indian high-net-worth individuals (HNIs) are not exiting their marquee assets, with any 'discounted' resale deals attributed to investor liquidity stress rather than geopolitical flight.

FMCG firms weigh price hikes as input costs rise

FMCG firms weigh price hikes as input costs rise

Rediff.com   6 Apr 2026

Fast-moving consumer goods (FMCG) companies are closely monitoring crude oil prices and considering low single-digit price increases, while consumer durables firms have already begun passing on significant price hikes to consumers due to rising input costs exacerbated by the West Asia conflict.

FMCG firms expect high single-digit growth in Q4FY26

FMCG firms expect high single-digit growth in Q4FY26

Rediff.com   4 Apr 2026

Fast-moving consumer goods (FMCG) companies like Dabur India and Marico anticipate high single-digit growth in Q4FY26, driven by strong domestic demand in India, which is helping to offset the negative impact of geopolitical conflicts in West Asia on their international businesses.

Easter Weekend Travel Picks Up

Easter Weekend Travel Picks Up

Rediff.com   3 Apr 2026

As temperatures rise, travellers are increasingly gravitating towards cooler climates, driving demand for hill stations such as Mussoorie, Munnar, Varkala, Ooty and Kodaikanal.

Noida International Airport: Property Prices Soar Along Yamuna Expressway

Noida International Airport: Property Prices Soar Along Yamuna Expressway

Rediff.com   30 Mar 2026

The inauguration of Noida International Airport (NIA) is set to significantly increase property values in micro-markets along the Yamuna Expressway, with projections indicating a 28 per cent rise for plots and 22 per cent for apartments over the next two years, according to Colliers.

West Asia Crisis Reroutes Tourists

West Asia Crisis Reroutes Tourists

Rediff.com   27 Mar 2026

'Travellers are considering safer and more stable destinations.'

Centre Cracks Down on GLP-1 Drug Misuse

Centre Cracks Down on GLP-1 Drug Misuse

Rediff.com   25 Mar 2026

Inspections conducted across 49 entities including pharmacies, wholesalers, and clinics to detect violations and misleading marketing practices.

Semaglutide Ruling Sparks Generic Pharma Boom

Semaglutide Ruling Sparks Generic Pharma Boom

Rediff.com   24 Mar 2026

At the heart of this debate is Section 3(d) of the Patents Act, a safeguard designed to prevent drugmakers from extending monopoly protection through trivial modifications to existing medicines.

Reality check gets India on investors' realty list

Reality check gets India on investors' realty list

Rediff.com   23 Mar 2026

Escalating geopolitical tensions in West Asia are prompting investors with exposure to Dubai's real estate market to reassess their portfolios. And, in this rejig, India is emerging as a stable destination for capital investment and long-term growth.

Weight Loss Drugs Set to Flood India

Weight Loss Drugs Set to Flood India

Rediff.com   16 Mar 2026

While the introduction of branded generics is likely to accelerate volumes for GLP-1 agonists, value growth may moderate because of price erosion.

US Business Schools Eye India Partnerships

US Business Schools Eye India Partnerships

Rediff.com   12 Mar 2026

The outreach comes amid a drop in Indian student enrolments in management programmes at American universities last year, following changes to US student visa policies.